
ECTRIMS 2010: Gothenburg, Sweden · 13-16 October 2010
305 | Almirall, Barcelona / ES |
109 | Astra Tech AB, Mölndal / SE |
201 | Bayer Schering Pharma AG, Berlin / DE |
205 | Biogen Idec, Zug / CH |
401 | Biogen Idec, Zug / CH |
101 | competence Network – Multiple Sclerosis, Munich / DE |
505 | ECTRIMS Congress 2011 |
303 | EDMUS, Lyon / FR |
301 | ESAOTE, Genoa / IT |
501 | European Charot Foundation, Molenhoek (Nijmegen) / NL |
507 | European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) |
317 | European MS Platform (EMSP), Bruxelles / BE |
509 | European Neurological Society (ENS), Basel / CH |
115 | Genzyme Corporation, Cambridge MA / US |
325 | Heidelberg Engineering GmbH, Heidelberg / DE |
203 | Merck Serono SA, Geneva / CH |
315 | MSBase Registry, Melbourne / AU |
307 | Multiple Sclerosis International Federation, London / UK |
313 | Novartis Pharma AG, Basel / CH |
321 | PBL InterferonSource, Piscataway / US |
103 | RIMS-Network of MS Centres, Europe |
207 | Sanofi-aventis, Paris / FR |
503 | Serono Symposia International Foundation, Rome / IT |
323 | Synovate Healthcare, London / UK |
107 | Talecris Biotherapeutics, Frankfurt / DE |
209 | Teva and Sanofi-aventis |
105 | Wisepress Ltd, London / UK |